MRPL39 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.917400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.816600E-01
Normal-vs-Stage2
2.930000E-01
Normal-vs-Stage3
3.831200E-01
Normal-vs-Stage4
4.217800E-03
Stage1-vs-Stage2
8.688600E-01
Stage1-vs-Stage3
9.329800E-01
Stage1-vs-Stage4
8.795400E-01
Stage2-vs-Stage3
9.928400E-01
Stage2-vs-Stage4
9.214600E-01
Stage3-vs-Stage4
9.797400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.783000E-01
Normal-vs-AfricanAmerican
4.482600E-01
Normal-vs-Asian
1.867820E-01
Caucasian-vs-AfricanAmerican
9.763200E-01
Caucasian-vs-Asian
9.765200E-01
AfricanAmerican-vs-Asian
9.755800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.437400E-01
Normal-vs-Female
3.725800E-01
Male-vs-Female
2.945000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.184500E-02
Normal-vs-Age(41-60Yrs)
4.022000E-01
Normal-vs-Age(61-80Yrs)
2.253000E-01
Normal-vs-Age(81-100Yrs)
7.710000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.190000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.491400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.270500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.756300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.710400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.136180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.662200E-01
Normal-vs-Daily Drinker
1.913620E-01
Normal-vs-Weekly Drinker
3.085600E-01
Normal-vs-Occasional Drinker
1.300840E-01
Normal-vs-Social Drinker
3.978400E-01
Non Drinker-vs-Daily Drinker
2.672200E-01
Non Drinker-vs-Weekly Drinker
7.908200E-01
Non Drinker-vs-Occasional Drinker
5.770000E-01
Non Drinker-vs-Social Drinker
5.550600E-01
Daily Drinker-vs-Weekly Drinker
5.054600E-01
Daily Drinker-vs-Occasional Drinker
5.616400E-01
Daily Drinker-vs-Social Drinker
1.261620E-01
Weekly Drinker-vs-Occasional Drinker
8.296400E-01
Weekly Drinker-vs-Social Drinker
4.236800E-01
Occasional Drinker-vs-Social Drinker
2.072800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.656380E-01
Normal-vs-Grade 2
8.864100E-02
Normal-vs-Grade 3
8.519600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.288400E-01
Grade 1-vs-Grade 3
3.067400E-01
Grade 1-vs-Grade 4
1.656380E-01
Grade 2-vs-Grade 3
6.766000E-01
Grade 2-vs-Grade 4
8.864100E-02
Grade 3-vs-Grade 4
8.519600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.266600E-01
Normal-vs-NonDiabetic
2.508400E-01
Diabetic-vs-NonDiabetic
8.696400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.509400E-01
Normal-vs-NoPancreatitis
2.437400E-01
Pancreatitis-vs-NoPancreatitis
9.223000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.433800E-01
Normal-vs-N1
2.990400E-01
N0-vs-N1
6.559000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.291600E-01
Normal-vs-TP53-NonMutant
4.234400E-01
TP53-Mutant-vs-TP53-NonMutant
8.152800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
